1Matsuyama A, Yamamoto H, Kobayashi Y. Practical application of recombinant whole - eell biocatalysts for the manufacturing of pharmaceutical intermediates such as chiral alcohols [ J ]. Org Process Res Dev ,2002,6 (4) :558 - 561.
2Bear MM, Monne C, Robic D, et al. Synthesis and polymerization of benzyl (3R, 4R) -3 - methylm alolactonate via enzymatic preparation of the chiral precursor [ J ]. Chirality, 1998,10 ( 8 ) : 727 -733.
3Bommarus AS, Polizzi KM. Novel biocatalysts: Recent developments[J]. Chem Eng Sci,2006,61 (6) :1004 - 1016.
5Erhardt PW, Woo CM, Gorczynski RJ, et al. Ultra - short - acting -adrenergic receptor blocking agents. 1. (aryloxy)propanolamines containing esters in the nitrogen substituent [ J ]. J Med Chem,1982,25(2) :1402 - 1407.
6Terao Y, Murata M, Achiwa K. Highly efficient lipase - catalyzed asymmetric synthesis of chiral glycerol derivatives leading to practical synthesis of (S) - propranolol[ J]. Tetrahedron Lett , 1988,29(40) : 5173 -5176.
7Cavallo AS, Bencheqroun M. N - isopropyl - N - methyl formamidine : a reagent for the synthesis of bioactive amino - alcohols[ J].Tetrahedron Lett,1990,31 ( 15 ) :2157 -2160.
8Veloo RA, Koomen GJ. Synthesis of enantiomerically pure (S) -(--) - propranolol from sorbito - 1 [ J ]. Tetrahedron: Asymmetry,1993,4(12) :2401 -2404.
9Krause HW, Schmidt U, Taudien S, et al. Aminophosphine phosphinites of propranolol analogues as ligands for Rh - catalyzed asymmetric hydrogenation [J]. J Mol Catal Chem A, 1995, 104(2) :147 - 157.
10Hou XL, Li BF, Dai LX. Synthesis of novel and enantiomefically pure epoxypropylamine: a divergent route to the chiral β - adren- ergic blocking agents [J]. Tetrahedron: Asymmetry, 1999, 10 (15) : 2319 - 2326.
